Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma.
As an oncoprotein, MDM4 plays a key part in P53 tumor suppressor pathway through negatively regulating P53 function. It has been reported that an rs4245739 A>C polymorphism locating in the MDM4 3'-untranslated region creates a miR-191 target site and results in decreased MDM4 expression. The...
Main Authors: | Liqing Zhou, Xiaojiao Zhang, Ziqiang Li, Changchun Zhou, Meng Li, Xiaohu Tang, Chao Lu, Helou Li, Qipeng Yuan, Ming Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3665831?pdf=render |
Similar Items
-
miR-191: An emerging player in disease biology
by: Ritu eKulshreshtha, et al.
Published: (2014-04-01) -
Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
by: Parisa Naeli, et al.
Published: (2017-11-01) -
A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
by: Feng Gao, et al.
Published: (2015-01-01) -
Hypomethylation of the hsa-miR-191 Locus Causes High Expression of hsa-miR-191 and Promotes the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
by: Yinghua He, et al.
Published: (2011-09-01) -
CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma
by: Shuwen Xu, et al.
Published: (2021-03-01)